SRZN
Surrozen Inc
NASDAQ: SRZN · HEALTHCARE · BIOTECHNOLOGY
$30.35
+2.78% today
Updated 2026-10-28
Market cap
$275.50M
P/E ratio
—
P/S ratio
23.93x
EPS (TTM)
$-39.08
Dividend yield
—
52W range
$11 – $38
Volume
0.6M
Surrozen Inc (SRZN) Insider transactions
Net insider activity
Net buying (1,798,161 shares)
Buy transactions
88
Sell transactions
12
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-22 | TCG, CROSSOVER GP II, LLC | 10% Owner | Sale | 162,500 | $21.25 | $3.45M |
| 2026-06-15 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 1,666 | $8.11 | $13511.26 |
| 2026-06-15 | PARKER, CRAIG C | Director, Chief Executive Officer | Buy | 1,622 | $8.11 | $13154.42 |
| 2026-06-15 | MALEKI, ANDREW PEDRUM | Chief Financial Officer | Buy | 607 | $19.01 | $11539.07 |
| 2026-06-15 | LI, YANG | Exec. Vice President, Research | Buy | 1,666 | $8.11 | $13511.26 |
| 2026-05-13 | WOODHOUSE, DAVID J | Director | Buy | 5,550 | — | — |
| 2026-05-13 | ROTHENBERG, MACE | Director | Buy | 5,550 | — | — |
| 2026-05-13 | KUTZKEY, TIM | Director, 10% Owner | Buy | 5,550 | — | — |
| 2026-05-13 | HAAK-FRENDSCHO, MARY | Director | Buy | 5,550 | — | — |
| 2026-05-13 | CHAI, CHRISTOPHER Y | Director | Buy | 5,550 | — | — |
| 2026-05-13 | BJERKHOLT, ERIC | Director | Buy | 5,550 | — | — |
| 2026-05-13 | BERKENBLIT, ANNA | Director | Buy | 5,550 | — | — |
| 2026-05-04 | WILLIAMS, CHARLES O | Chief Operating Officer | Sale | 2,036 | $33.33 | $67865.58 |
| 2026-05-04 | PARKER, CRAIG C | Director, Chief Executive Officer | Sale | 4,524 | $33.33 | $150797.59 |
| 2026-05-04 | LI, YANG | Exec. Vice President, Research | Sale | 1,584 | $33.33 | $52799.16 |
| 2026-05-01 | WILLIAMS, CHARLES O | Chief Operating Officer | Sale | 5,625 | — | — |
| 2026-05-01 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 5,625 | — | — |
| 2026-05-01 | PARKER, CRAIG C | Director, Chief Executive Officer | Sale | 12,500 | — | — |
| 2026-05-01 | PARKER, CRAIG C | Director, Chief Executive Officer | Buy | 12,500 | — | — |
| 2026-05-01 | LI, YANG | Exec. Vice President, Research | Sale | 4,375 | — | — |
| 2026-05-01 | LI, YANG | Exec. Vice President, Research | Buy | 4,375 | — | — |
| 2026-03-31 | LI, YANG | Exec. Vice President, Research | Sale | 1,666 | — | — |
| 2026-03-24 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 53,329 | $24.69 | $1.32M |
| 2026-03-23 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 7,612 | $24.90 | $189538.04 |
| 2026-03-23 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 7,611 | $24.90 | $189513.14 |
| 2026-03-16 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 595 | $24.99 | $14866.49 |
| 2026-03-13 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 17,717 | $24.88 | $440744.04 |
| 2026-03-13 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 17,716 | $24.88 | $440719.16 |
| 2026-03-12 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 6,187 | $24.99 | $154582.81 |
| 2026-02-17 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 102,900 | — | — |
| 2026-02-17 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 102,900 | — | — |
| 2026-02-17 | PARKER, CRAIG C | Director, Chief Executive Officer | Buy | 242,200 | — | — |
| 2026-02-17 | PARKER, CRAIG C | Director, Chief Executive Officer | Buy | 242,200 | — | — |
| 2026-02-17 | LI, YANG | Exec. Vice President, Research | Buy | 100,950 | — | — |
| 2026-02-17 | LI, YANG | Exec. Vice President, Research | Buy | 100,950 | — | — |
| 2026-02-12 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 547 | $23.86 | $13052.79 |
| 2026-02-12 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 546 | $23.86 | $13028.93 |
| 2026-02-11 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 8,882 | $23.58 | $209393.15 |
| 2026-02-11 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 8,881 | $23.58 | $209369.57 |
| 2026-02-03 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 2,178 | $21.94 | $47785.32 |
| 2026-02-03 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 2,177 | $21.94 | $47763.38 |
| 2026-02-02 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 366 | $21.38 | $7825.08 |
| 2026-02-02 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 365 | $21.38 | $7803.70 |
| 2026-01-30 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 2,136 | $21.39 | $45689.04 |
| 2026-01-30 | TCG, CROSSOVER GP II, LLC | 10% Owner | Buy | 2,135 | $21.39 | $45667.65 |
| 2026-01-23 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 500 | — | — |
| 2026-01-20 | KUTZKEY, TIM | Director, 10% Owner | Buy | 9,568 | $19.60 | $187531.84 |
| 2026-01-20 | KUTZKEY, TIM | Director, 10% Owner | Buy | 8,484 | $19.60 | $166285.55 |
| 2026-01-20 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 9,568 | $19.60 | $187531.84 |
| 2026-01-20 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 8,484 | $19.60 | $166285.55 |
| 2026-01-16 | KUTZKEY, TIM | Director, 10% Owner | Buy | 1,358 | $20.00 | $27160.00 |
| 2026-01-16 | KUTZKEY, TIM | Director, 10% Owner | Buy | 1,204 | $20.00 | $24080.00 |
| 2026-01-16 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 1,358 | $20.00 | $27160.00 |
| 2026-01-16 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 1,204 | $20.00 | $24080.00 |
| 2026-01-15 | KUTZKEY, TIM | Director, 10% Owner | Buy | 6,303 | $19.89 | $125360.37 |
| 2026-01-15 | KUTZKEY, TIM | Director, 10% Owner | Buy | 5,590 | $19.89 | $111179.51 |
| 2026-01-15 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 6,303 | $19.89 | $125360.37 |
| 2026-01-15 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 5,590 | $19.89 | $111179.51 |
| 2026-01-14 | KUTZKEY, TIM | Director, 10% Owner | Buy | 2,927 | $19.99 | $58505.75 |
| 2026-01-14 | KUTZKEY, TIM | Director, 10% Owner | Buy | 2,596 | $19.99 | $51889.63 |
| 2026-01-14 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 2,927 | $19.99 | $58505.75 |
| 2026-01-14 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 2,596 | $19.99 | $51889.63 |
| 2026-01-13 | KUTZKEY, TIM | Director, 10% Owner | Buy | 6,609 | $19.80 | $130885.30 |
| 2026-01-13 | KUTZKEY, TIM | Director, 10% Owner | Buy | 5,861 | $19.80 | $116071.83 |
| 2026-01-13 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 6,609 | $19.80 | $130885.30 |
| 2026-01-13 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 5,861 | $19.80 | $116071.83 |
| 2026-01-06 | KUTZKEY, TIM | Director, 10% Owner | Buy | 8,003 | $19.89 | $159157.26 |
| 2026-01-06 | KUTZKEY, TIM | Director, 10% Owner | Buy | 7,097 | $19.89 | $141139.46 |
| 2026-01-06 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 8,003 | $19.89 | $159157.26 |
| 2026-01-06 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 7,097 | $19.89 | $141139.46 |
| 2026-01-05 | WILLIAMS, CHARLES O | Chief Operating Officer | Sale | 1,566 | $19.87 | $31108.90 |
| 2026-01-05 | LI, YANG | Exec. Vice President, Research | Sale | 1,118 | $19.87 | $22209.29 |
| 2026-01-02 | WILLIAMS, CHARLES O | Chief Operating Officer | Sale | 3,500 | — | — |
| 2026-01-02 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 3,500 | — | — |
| 2026-01-02 | LI, YANG | Exec. Vice President, Research | Sale | 2,500 | — | — |
| 2026-01-02 | LI, YANG | Exec. Vice President, Research | Buy | 2,500 | — | — |
| 2025-12-15 | WILLIAMS, CHARLES O | Chief Operating Officer | Buy | 1,666 | $8.11 | $13511.26 |
| 2025-12-15 | PARKER, CRAIG C | Director, Chief Executive Officer | Buy | 1,553 | $8.11 | $12594.83 |
| 2025-12-15 | LI, YANG | Exec. Vice President, Research | Buy | 1,666 | $8.11 | $13511.26 |
| 2025-12-05 | KUTZKEY, TIM | Director, 10% Owner | Buy | 16,381 | $19.54 | $320099.48 |
| 2025-12-05 | KUTZKEY, TIM | Director, 10% Owner | Buy | 14,503 | $19.54 | $283401.67 |
| 2025-12-05 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 16,381 | $19.54 | $320099.48 |
| 2025-12-05 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 14,503 | $19.54 | $283401.67 |
| 2025-12-04 | KUTZKEY, TIM | Director, 10% Owner | Buy | 2,791 | $17.35 | $48415.48 |
| 2025-12-04 | KUTZKEY, TIM | Director, 10% Owner | Buy | 2,475 | $17.35 | $42933.83 |
| 2025-12-04 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 2,791 | $17.35 | $48415.48 |
| 2025-12-04 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 2,475 | $17.35 | $42933.83 |
| 2025-11-13 | KUTZKEY, TIM | Director, 10% Owner | Buy | 167,307 | $12.65 | $2.12M |
| 2025-11-13 | KUTZKEY, TIM | Director, 10% Owner | Buy | 148,150 | $12.65 | $1.87M |
| 2025-11-13 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 167,307 | $12.65 | $2.12M |
| 2025-11-13 | COLUMN, GROUP III GP, LP | 10% Owner | Buy | 148,150 | $12.65 | $1.87M |
| 2025-11-12 | MALEKI, ANDREW PEDRUM | Chief Financial Officer | Buy | 50,000 | — | — |
| 2025-06-13 | WILLIAMS, CHARLES O | CFO and COO | Buy | 400 | $8.06 | $3224.00 |
| 2025-06-13 | PARKER, CRAIG C | Director, Chief Executive Officer | Buy | 400 | $8.06 | $3224.00 |
| 2025-06-13 | LI, YANG | Exec. Vice President, Research | Buy | 400 | $8.06 | $3224.00 |
| 2025-05-14 | WOODHOUSE, DAVID J | Director | Buy | 1,333 | — | — |
| 2025-05-14 | ROTHENBERG, MACE | Director | Buy | 1,333 | — | — |
| 2025-05-14 | LIN, SHAO-LEE | Director | Buy | 1,333 | — | — |
| 2025-05-14 | HAAK-FRENDSCHO, MARY | Director | Buy | 1,333 | — | — |
| 2025-05-14 | CHAI, CHRISTOPHER Y | Director | Buy | 1,333 | — | — |
Frequently asked questions
Are SRZN insiders buying or selling?
Over the transactions on record, SRZN insiders have been net buyers, with about $3.78M in stock sold across 12 sales, against 63 open-market purchases.
Does insider selling at SRZN mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which SRZN insiders are selling the most?
Recent selling is concentrated in a few names. TCG, CROSSOVER GP II, LLC accounts for the largest share on record, with about $3.45M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.